Table 3.
All n = 118 |
CVVH n = 35 |
CVVHD-HCO n = 31 |
CVVHD-ads n = 7 |
CVVHDF n = 9 |
CVVHD/SLEDD n = 23 |
Othersa n = 13 |
|
---|---|---|---|---|---|---|---|
MRR (%) | 49.5 [30.8; 72.3] | 64 [38; 81] | 61 [26.5; 74.3] | 45 [35.3; 56.3] | 33 [00; 48] | 42 [20; 69] | |
P# | 0.7 | 0.266 | 0.787 | 0.161 | 0.708 |
ads. Adsorber, CVVH Continuous veno-venous hemofiltration, CVVHD Continuous veno-venous hemodialysis, CVVHDF Continuous veno-venous hemodiafiltration, HCO High cut-off, MRR Myoglobin reduction rate, SLEDD Sustained low-efficiency daily dialysis
#Specific extracorporeal procedure compared with all other KRT modalities
aOthers include KRT later during ICU stay and combination of more than one specific KRT: data not shown